Yes, but fair skin requires longer loading (3 to 4 weeks instead of 1 to 2 weeks) and higher cumulative doses (20 to 50 mg instead of 5 to 10 mg)
Today, were diving deep into two of the most talked about GLP-based weight-management therapies: Semaglutide and Tirzepatide
Tirzepatide, a single molecule, acts as a dual agonist, targeting GLP-1 and gastric inhibitory peptide (GIP) receptors
The diagram below illustrates a current snapshot of the intense competition in the weight loss landscape: Visual Credit: Sophia Rawson, Chike Onyia, Nicholas Colaw As the AOM market continues to grow, manufacturers must navigate a range of critical market dynamics, including emerging access dynamics, clinical differentiation needs, patient access challenges, and emerging opportunities for partnerships